PREVYMIS
Generic: LETERMOVIR
Merck Sharp & Dohme LLCManufacturer
ORALRoute
LETERMOVIRActive Substance
2024-08-30Original Approval
PREVYMIS is FDA application NDA219104, sponsored by MSD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
689 reports
2
DRUG INEFFECTIVE
277 reports
3
CYTOMEGALOVIRUS INFECTION REACTIVATION
242 reports
4
DEATH
197 reports
5
CYTOMEGALOVIRUS INFECTION
171 reports
6
ACUTE KIDNEY INJURY
170 reports
7
DRUG INTERACTION
165 reports
8
PRODUCT USE IN UNAPPROVED INDICATION
158 reports
9
PANCYTOPENIA
148 reports
10
CYTOMEGALOVIRUS VIRAEMIA
96 reports